Flares in pediatric systemic lupus erythematosus

Jennifer E. Weiss, Cristina P. Sison, Norman Todd Ilowite, Beth S. Gottlieb, Barbara A. Eberhard

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective. To determine the flare rate and the change in Safety of Estrogens in Lupus Erythematosus: National Assessment Systemic Lupus Erythematosus Disease Activity Index (SELENA SLEDAI) score with disease flare in pediatric systemic lupus erythematosus (pSLE). Methods. A retrospective chart review of 62 patients with pSLE (ages 5-20 yrs). A flare was defined as the start of, or increase in, the dose of corticosteroids and/or the addition of an immunosuppressive medication. All pre-flare, flare, and post-flare visits were recorded with a SELENA SLEDAI score calculated for each visit. The flare rate was calculated by dividing the total number of flares in the cohort by the total followup years. Results. Sixty-two patients were eligible. Forty-seven patients had 112 flares. The average number of flares/patient was 1.8 ± 2.0 and the mean inter-flare time was 15.4 ± 17.9 months. The flare rate in pSLE was 0.46 flares/patient-year of followup. The median time to first flare from the date of diagnosis was 14.3 months. Patients with cytopenia, pleuritis, or pericarditis, or a positive antibody to Smith nuclear antigen at the time of diagnosis had a significantly higher flare rate than those who did not. The average SELENA SLEDAI score at presentation was 12.5 ± 5.4, at the pre-flare visit 6.3 ± 3.5, and during a flare 7.9 ± 5.1. Conclusion. This is the first large study to report a flare rate (0.46 flares/patient-year of followup) in pSLE. The flare rate was similar to what has been reported in pSLE previously but significantly lower than that reported in adults with lupus. The average change in the SELENA SLEDAI score with disease flare is 2 points.

Original languageEnglish (US)
Pages (from-to)1341-1344
Number of pages4
JournalJournal of Rheumatology
Volume34
Issue number6
StatePublished - Jun 2007

Fingerprint

Systemic Lupus Erythematosus
Pediatrics
Estrogens
Safety
Nuclear Antigens
Pleurisy
Pericarditis
Immunosuppressive Agents
Adrenal Cortex Hormones
Antibodies

Keywords

  • Flare rate
  • Pediatric rheumatology
  • SELENA SLEDAI
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Weiss, J. E., Sison, C. P., Ilowite, N. T., Gottlieb, B. S., & Eberhard, B. A. (2007). Flares in pediatric systemic lupus erythematosus. Journal of Rheumatology, 34(6), 1341-1344.

Flares in pediatric systemic lupus erythematosus. / Weiss, Jennifer E.; Sison, Cristina P.; Ilowite, Norman Todd; Gottlieb, Beth S.; Eberhard, Barbara A.

In: Journal of Rheumatology, Vol. 34, No. 6, 06.2007, p. 1341-1344.

Research output: Contribution to journalArticle

Weiss, JE, Sison, CP, Ilowite, NT, Gottlieb, BS & Eberhard, BA 2007, 'Flares in pediatric systemic lupus erythematosus', Journal of Rheumatology, vol. 34, no. 6, pp. 1341-1344.
Weiss JE, Sison CP, Ilowite NT, Gottlieb BS, Eberhard BA. Flares in pediatric systemic lupus erythematosus. Journal of Rheumatology. 2007 Jun;34(6):1341-1344.
Weiss, Jennifer E. ; Sison, Cristina P. ; Ilowite, Norman Todd ; Gottlieb, Beth S. ; Eberhard, Barbara A. / Flares in pediatric systemic lupus erythematosus. In: Journal of Rheumatology. 2007 ; Vol. 34, No. 6. pp. 1341-1344.
@article{3e85e689a50a4e809d598f70391f747d,
title = "Flares in pediatric systemic lupus erythematosus",
abstract = "Objective. To determine the flare rate and the change in Safety of Estrogens in Lupus Erythematosus: National Assessment Systemic Lupus Erythematosus Disease Activity Index (SELENA SLEDAI) score with disease flare in pediatric systemic lupus erythematosus (pSLE). Methods. A retrospective chart review of 62 patients with pSLE (ages 5-20 yrs). A flare was defined as the start of, or increase in, the dose of corticosteroids and/or the addition of an immunosuppressive medication. All pre-flare, flare, and post-flare visits were recorded with a SELENA SLEDAI score calculated for each visit. The flare rate was calculated by dividing the total number of flares in the cohort by the total followup years. Results. Sixty-two patients were eligible. Forty-seven patients had 112 flares. The average number of flares/patient was 1.8 ± 2.0 and the mean inter-flare time was 15.4 ± 17.9 months. The flare rate in pSLE was 0.46 flares/patient-year of followup. The median time to first flare from the date of diagnosis was 14.3 months. Patients with cytopenia, pleuritis, or pericarditis, or a positive antibody to Smith nuclear antigen at the time of diagnosis had a significantly higher flare rate than those who did not. The average SELENA SLEDAI score at presentation was 12.5 ± 5.4, at the pre-flare visit 6.3 ± 3.5, and during a flare 7.9 ± 5.1. Conclusion. This is the first large study to report a flare rate (0.46 flares/patient-year of followup) in pSLE. The flare rate was similar to what has been reported in pSLE previously but significantly lower than that reported in adults with lupus. The average change in the SELENA SLEDAI score with disease flare is 2 points.",
keywords = "Flare rate, Pediatric rheumatology, SELENA SLEDAI, Systemic lupus erythematosus",
author = "Weiss, {Jennifer E.} and Sison, {Cristina P.} and Ilowite, {Norman Todd} and Gottlieb, {Beth S.} and Eberhard, {Barbara A.}",
year = "2007",
month = "6",
language = "English (US)",
volume = "34",
pages = "1341--1344",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "6",

}

TY - JOUR

T1 - Flares in pediatric systemic lupus erythematosus

AU - Weiss, Jennifer E.

AU - Sison, Cristina P.

AU - Ilowite, Norman Todd

AU - Gottlieb, Beth S.

AU - Eberhard, Barbara A.

PY - 2007/6

Y1 - 2007/6

N2 - Objective. To determine the flare rate and the change in Safety of Estrogens in Lupus Erythematosus: National Assessment Systemic Lupus Erythematosus Disease Activity Index (SELENA SLEDAI) score with disease flare in pediatric systemic lupus erythematosus (pSLE). Methods. A retrospective chart review of 62 patients with pSLE (ages 5-20 yrs). A flare was defined as the start of, or increase in, the dose of corticosteroids and/or the addition of an immunosuppressive medication. All pre-flare, flare, and post-flare visits were recorded with a SELENA SLEDAI score calculated for each visit. The flare rate was calculated by dividing the total number of flares in the cohort by the total followup years. Results. Sixty-two patients were eligible. Forty-seven patients had 112 flares. The average number of flares/patient was 1.8 ± 2.0 and the mean inter-flare time was 15.4 ± 17.9 months. The flare rate in pSLE was 0.46 flares/patient-year of followup. The median time to first flare from the date of diagnosis was 14.3 months. Patients with cytopenia, pleuritis, or pericarditis, or a positive antibody to Smith nuclear antigen at the time of diagnosis had a significantly higher flare rate than those who did not. The average SELENA SLEDAI score at presentation was 12.5 ± 5.4, at the pre-flare visit 6.3 ± 3.5, and during a flare 7.9 ± 5.1. Conclusion. This is the first large study to report a flare rate (0.46 flares/patient-year of followup) in pSLE. The flare rate was similar to what has been reported in pSLE previously but significantly lower than that reported in adults with lupus. The average change in the SELENA SLEDAI score with disease flare is 2 points.

AB - Objective. To determine the flare rate and the change in Safety of Estrogens in Lupus Erythematosus: National Assessment Systemic Lupus Erythematosus Disease Activity Index (SELENA SLEDAI) score with disease flare in pediatric systemic lupus erythematosus (pSLE). Methods. A retrospective chart review of 62 patients with pSLE (ages 5-20 yrs). A flare was defined as the start of, or increase in, the dose of corticosteroids and/or the addition of an immunosuppressive medication. All pre-flare, flare, and post-flare visits were recorded with a SELENA SLEDAI score calculated for each visit. The flare rate was calculated by dividing the total number of flares in the cohort by the total followup years. Results. Sixty-two patients were eligible. Forty-seven patients had 112 flares. The average number of flares/patient was 1.8 ± 2.0 and the mean inter-flare time was 15.4 ± 17.9 months. The flare rate in pSLE was 0.46 flares/patient-year of followup. The median time to first flare from the date of diagnosis was 14.3 months. Patients with cytopenia, pleuritis, or pericarditis, or a positive antibody to Smith nuclear antigen at the time of diagnosis had a significantly higher flare rate than those who did not. The average SELENA SLEDAI score at presentation was 12.5 ± 5.4, at the pre-flare visit 6.3 ± 3.5, and during a flare 7.9 ± 5.1. Conclusion. This is the first large study to report a flare rate (0.46 flares/patient-year of followup) in pSLE. The flare rate was similar to what has been reported in pSLE previously but significantly lower than that reported in adults with lupus. The average change in the SELENA SLEDAI score with disease flare is 2 points.

KW - Flare rate

KW - Pediatric rheumatology

KW - SELENA SLEDAI

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=34250222120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250222120&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 1341

EP - 1344

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 6

ER -